Valuation: Ibnsina Pharma

Market Cap 10.61B 198M 180M 166M 150M 283M 18.57B 293M 2B 791M 9.96B 742M 726M 31.56B P/E 2026 *
9.32x
P/E 2027 * 7.13x
Enterprise Value 19.24B 359M 326M 301M 272M 513M 33.66B 531M 3.62B 1.43B 18.07B 1.35B 1.32B 57.22B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.17x
Free-Float
58.26%
Yield 2026 *
2.75%
Yield 2027 * 3.89%
1 day+2.13%
1 week+1.64%
Current month+5.41%
1 month-6.57%
3 months-22.29%
6 months-10.38%
Current year-10.15%
1 week 10.19
Extreme 10.19
10.72
1 month 9.02
Extreme 9.02
11.26
Current year 9.02
Extreme 9.02
16.93
1 year 9.02
Extreme 9.02
16.93
3 years 2.14
Extreme 2.14
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%+1.64%-0.66%+336.93% 195M
+1.52%-4.58%-39.96%+2.30% 16.53B
-0.54%+3.17%-6.67%+3.36% 7.1B
+1.40%+7.40%+6.50%+15.64% 6.89B
+2.45%-5.65%-50.51%-41.27% 5.88B
+2.71%-3.32%+5.18%-17.49% 4.63B
-23.27%-5.06%-37.18%-47.43% 4.43B
+1.66%-3.26%+11.71%-19.57% 3.49B
+1.06%+4.62%-12.42%-28.96% 3.26B
-0.07%+4.77%-16.72%+36.86% 3.3B
Average -1.10%+1.16%-14.07%+24.04% 6B
Weighted average by Cap. -0.64%-0.29%-20.75%-6.10%

Financials

2026 *2027 *
Net sales 94.39B 1.76B 1.6B 1.48B 1.33B 2.52B 165B 2.6B 17.75B 7.03B 88.61B 6.6B 6.46B 281B 103B 1.91B 1.74B 1.61B 1.45B 2.74B 180B 2.84B 19.33B 7.66B 96.49B 7.19B 7.03B 306B
Net income 1.18B 22.04M 20.02M 18.5M 16.71M 31.54M 2.07B 32.65M 222M 88.15M 1.11B 82.7M 80.95M 3.52B 1.58B 29.49M 26.79M 24.75M 22.36M 42.19M 2.77B 43.67M 298M 118M 1.49B 111M 108M 4.71B
Net Debt 8.63B 161M 146M 135M 122M 230M 15.1B 238M 1.62B 643M 8.1B 603M 591M 25.66B 6.81B 127M 115M 107M 96.25M 182M 11.92B 188M 1.28B 508M 6.4B 476M 466M 20.26B
Projected Income Statement - Annual - Ibnsina Pharma
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-11-16 EGP 10.53 +2.13% 10,381,140
26-11-15 EGP 10.31 -0.19% 6,810,856
26-11-12 EGP 10.33 -0.39% 3,379,985
26-11-11 EGP 10.37 -2.17% 5,903,755
26-11-10 EGP 10.60 +1.24% 6,303,575
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ibnsina Pharma
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.53EGP
Average target price
16.51EGP
Spread / Average Target
+56.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ibnsina Pharma
  1. Stock Market
  2. Stocks
  3. ISPH Stock